Grifols (GIFLF) Current Taxes (2010 - 2025)
Grifols (GIFLF) reported Current Taxes of $29.1 million for Q4 2025, down 55.36% on a YoY basis from $65.2 million in Q4 2024, and down 55.36% quarter-over-quarter from $65.2 million in Q4 2024.
Grifols (GIFLF) Current Taxes (2010 - 2025) Analysis & Trends
Grifols has reported Current Taxes for 16 years, with the latest figure at $29.1 million in Q4 2025.
- For the quarter ending Q4 2025, Current Taxes fell 55.36% year-over-year to $29.1 million; the trailing twelve-month figure through Dec 2025 stood at $29.1 million (down 55.36% YoY), and the FY2025 full-year result was $29.1 million, down 55.36% from the prior year.
- Current Taxes for Q4 2025 stood at $29.1 million, down from $65.2 million in the prior quarter.
- The five-year high for Current Taxes was $65.2 million in Q4 2024, with the low at $5.2 million in Q4 2021.
- Historically, Current Taxes has averaged $26.2 million across 5 years, with a median of $16.0 million in 2022.
- Annual changes were most pronounced in 2024 — Current Taxes soared 317.16% — and 2025, when it plunged 55.36%.
- Grifols' Current Taxes stood at $5.2 million in 2021, then surged by 209.8% to $16.0 million in 2022, then decreased by 2.37% to $15.6 million in 2023, then soared by 317.16% to $65.2 million in 2024, then sank by 55.36% to $29.1 million in 2025.
- The last three Current Taxes figures came in at $29.1 million (Q4 2025), $65.2 million (Q4 2024), and $15.6 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 96,436,181.12 Bn | 96,436,176.16 Bn | 7.76 Bn | -748.24 Mn |
| 2 | Eli Lilly | 1,017.30 Bn | 1,012.01 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 579.61 Bn | 557.55 Bn | 15.96 Bn | 1.09 Bn |
| 4 | AbbVie | 402.30 Bn | 392.96 Bn | 10.78 Bn | - |
| 5 | Merck | 294.24 Bn | 288.59 Bn | 12.09 Bn | 3.95 Bn |
| 6 | Amgen | 191.82 Bn | 179.78 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | - |
| 8 | Pfizer | 149.05 Bn | 136.28 Bn | -1.21 Bn | 3.13 Bn |
| 9 | Bristol Myers Squibb | 116.33 Bn | 105.88 Bn | 8.07 Bn | - |
| 10 | Grifols | - | - | - | 29.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.10 Mn |
| Dec 31, 2024 | 65.18 Mn |
| Dec 31, 2023 | 15.63 Mn |
| Dec 31, 2022 | 16.00 Mn |
| Dec 31, 2021 | 5.17 Mn |
| Dec 31, 2020 | 4.15 Mn |
| Dec 31, 2019 | 6.60 Mn |
| Dec 31, 2018 | 2.19 Mn |
| Jun 30, 2018 | 24.20 Mn |
| Dec 31, 2017 | 7.90 Mn |
| Jun 30, 2017 | 23.02 Mn |
| Dec 31, 2016 | 8.59 Mn |
| Sep 30, 2016 | 24.51 Mn |
| Jun 30, 2016 | 36.95 Mn |
| Dec 31, 2015 | 17.75 Mn |
| Sep 30, 2015 | 43.88 Mn |
| Jun 30, 2015 | 107,468.36 |
| Mar 31, 2015 | 113.58 Mn |
| Dec 31, 2014 | 109.31 Mn |
| Dec 31, 2013 | 3.99 Mn |